SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advik Lab - Quaterly Results

21 May 2022 Evaluate
The revenue for the March 2022 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Total Profit for the quarter ended March 2022 of Rs. 4.26 millions grew from Rs.-1.52 millions Operating profit Margin for the quarter ended March 2022 further decreased to -1.85% as compared to -0.38% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.32 0.00 0.00 0.32 0.00 0.00
Other Income 0.04 1.82 -97.80 2.58 1.95 32.31 2.58 1.95 32.31
PBIDT -1.85 -0.38 386.84 -4.17 -39.37 -89.41 -4.17 -39.37 -89.41
Interest 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.01 0.00
PBDT -1.85 -0.38 386.84 -4.18 -39.38 -89.39 -4.18 -39.38 -89.39
Depreciation 1.28 1.31 -2.29 5.14 5.56 -7.55 5.14 5.56 -7.55
PBT -3.13 -1.69 85.21 -9.32 -44.94 -79.26 -9.32 -44.94 -79.26
TAX -7.39 -0.17 4247.06 -7.91 -0.78 914.10 -7.91 -0.78 914.10
Deferred Tax -3.80 -0.17 2135.29 -4.32 -0.78 453.85 -4.32 -0.78 453.85
PAT 4.26 -1.52 -380.26 -1.41 -44.16 -96.81 -1.41 -44.16 -96.81
Equity 191.11 191.11 0.00 191.11 191.11 0.00 191.11 191.11 0.00
PBIDTM(%) 0.00 0.00 0.00 -1303.13 0.00 0.00 -1303.13 0.00 0.00

MPS Pharmaa Share Price

1.73 0.00 (0.00%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1677.10
Dr. Reddys Lab 1238.25
Cipla 1238.70
Zydus Lifesciences 941.50
Lupin 2327.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×